From: ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy
Lines
ATP1A1 mRNA
Ic50 bufalin (nM)
HBL
0.000063
2.10
HBL-R
0.000078
1.20
MM074
0.000034
3.40
MM074-R
0.000031
2.40
MM161
0.000005
9.10
MM161-R
0.000022
9.60